1 | presence | 22,771 |
2 | absence | 9,285 |
3 | existence | 1,512 |
4 | metaregister | 255 |
5 | presence/absence | 109 |
6 | perpetuation | 47 |
7 | advisability | 20 |
8 | pervasiveness | 19 |
9 | abolishment | 15 |
10 | conclusiveness | 15 |
11 | absence/presence | 11 |
12 | orchestration | 10 |
13 | photophysics | 10 |
14 | supremacy | 10 |
15 | adaptiveness | 8 |
16 | 4'-position | 7 |
17 | enormity | 7 |
18 | sultanate | 7 |
19 | non-occurrence | 6 |
20 | principality | 6 |
21 | 'proportion | 5 |
22 | cocirculation | 5 |
23 | nonreceipt | 5 |
24 | patho-physiology | 5 |
25 | pathoetiology | 5 |
26 | presences | 5 |
27 | earliness | 4 |
28 | newness | 4 |
29 | over-expressions | 4 |
30 | rv-5h-egfp | 4 |
31 | transactivity | 4 |
32 | 3-alkenylation | 3 |
33 | 3-alkylation | 3 |
34 | explicitness | 3 |
35 | fracture/operation | 3 |
36 | full-texts | 3 |
37 | ionicity | 3 |
38 | multifunctionality | 3 |
39 | nonexistence | 3 |
40 | re-appearance | 3 |
41 | regimentation | 3 |
42 | sugammadex-rocuronium | 3 |
43 | up-take | 3 |
44 | 'characteristics | 2 |
45 | arg-vx001 | 2 |
46 | arm-forearm | 2 |
47 | avirulence | 2 |
48 | beef-consumption | 2 |
49 | cav- | 2 |
50 | cis-regulation | 2 |
51 | curer | 2 |
52 | curve-ness | 2 |
53 | disunity | 2 |
54 | dose/type | 2 |
55 | ecws | 2 |
56 | efficicacy | 2 |
57 | ethylacetate-fraction | 2 |
58 | extrudability | 2 |
59 | freguency | 2 |
60 | greying | 2 |
61 | hydrophosphination | 2 |
62 | imperfectness | 2 |
63 | inhibition/depletion | 2 |
64 | instalment | 2 |
65 | load-dependence | 2 |
66 | next-of-kin | 2 |
67 | non-adenomatous | 2 |
68 | non-eruption | 2 |
69 | non-presence | 2 |
70 | ocurrence | 2 |
71 | permissibility | 2 |
72 | pervasion | 2 |
73 | quick-disabilities | 2 |
74 | reinstallation | 2 |
75 | revitalisation | 2 |
76 | rls-quality | 2 |
77 | score/duration | 2 |
78 | shade-drying | 2 |
79 | theorisation | 2 |
80 | thrombovasculitis | 2 |
81 | timecourse | 2 |
82 | type-conformity | 2 |
83 | underweighting | 2 |
84 | 'region | 1 |
85 | 'toxemia | 1 |
86 | 0-6-month | 1 |
87 | 0.1mg/g | 1 |
88 | 0.450mg | 1 |
89 | 16g/day | 1 |
90 | 2,6-dideoxyhexoses | 1 |
91 | 23-o-methylation | 1 |
92 | 3'-amp-induced | 1 |
93 | 3-o-acetylation | 1 |
94 | 3.2g | 1 |
95 | 5-methoxy-moieties | 1 |
96 | 54mg | 1 |
97 | 5drop/kg | 1 |
98 | 8,9-positions | 1 |
99 | =2/5 | 1 |
100 | acute-exacerbations | 1 |
101 | adolescent-report | 1 |
102 | aleviations | 1 |
103 | anatomical/physiological | 1 |
104 | andinjustice | 1 |
105 | antennal- | 1 |
106 | anti-conservatism | 1 |
107 | axilla-surgery | 1 |
108 | banishment | 1 |
109 | bprs-score | 1 |
110 | brief-symptom-inventory-18 | 1 |
111 | broadbeam | 1 |
112 | bypass/resection | 1 |
113 | c1-carboxyl | 1 |
114 | ca2+-permeability | 1 |
115 | cattaneo-vernotte | 1 |
116 | cdc28 | 1 |
117 | cdh1-347g/ga | 1 |
118 | clarithromycin-amoxicillin | 1 |
119 | classical- | 1 |
120 | clinical-course | 1 |
121 | co-inhibitors | 1 |
122 | conut® | 1 |
123 | county- | 1 |
124 | cu-se | 1 |
125 | culture-negatives | 1 |
126 | cytodestruction | 1 |
127 | dam-to-placenta | 1 |
128 | decompression/release | 1 |
129 | deimplementation | 1 |
130 | dendrimerization | 1 |
131 | di-sulfate | 1 |
132 | didactic-only | 1 |
133 | disbeliefs | 1 |
134 | disease-spectrum | 1 |
135 | disproof | 1 |
136 | dw-r. | 1 |
137 | eclabion | 1 |
138 | endodrainage | 1 |
139 | entranceability | 1 |
140 | eortc-qlqc30 | 1 |
141 | erk- | 1 |
142 | eurotiales | 1 |
143 | f-60 | 1 |
144 | face/forehead | 1 |
145 | gastrin- | 1 |
146 | globality | 1 |
147 | gut-hepatic | 1 |
148 | hemorrhea | 1 |
149 | ho/co | 1 |
150 | hypermethylations | 1 |
151 | hypopnoea/hour | 1 |
152 | initial-pat | 1 |
153 | intermediating | 1 |
154 | jeju-do | 1 |
155 | keratitis/keratopathy | 1 |
156 | ldlr-cc | 1 |
157 | levels/patterns | 1 |
158 | liberal- | 1 |
159 | liquidform | 1 |
160 | lodogen | 1 |
161 | m-methoxyphenyl | 1 |
162 | maxillary- | 1 |
163 | menbunong | 1 |
164 | mensapo | 1 |
165 | mid-wbc | 1 |
166 | midazolam-group | 1 |
167 | midvault | 1 |
168 | minutia | 1 |
169 | mono-beta-xyloside | 1 |
170 | mono-ubiquitylation | 1 |
171 | msus- | 1 |
172 | myth-reality | 1 |
173 | n109 | 1 |
174 | naguales | 1 |
175 | near-clearing | 1 |
176 | nerve-nerve | 1 |
177 | nhe6 | 1 |
178 | nickel-producing | 1 |
179 | non-collection | 1 |
180 | non-consumption | 1 |
181 | nonactivation | 1 |
182 | nonpractice | 1 |
183 | nonrespect | 1 |
184 | o-iodoanilides | 1 |
185 | off-warfarin | 1 |
186 | over-ordination | 1 |
187 | over-recording | 1 |
188 | overgrading | 1 |
189 | overthinning | 1 |
190 | persistence/calcification | 1 |
191 | petichiae | 1 |
192 | post-clamping | 1 |
193 | pou5f1- | 1 |
194 | preemption | 1 |
195 | psc833- | 1 |
196 | pseudo-delayedness | 1 |
197 | purveyor | 1 |
198 | raloxifene- | 1 |
199 | reconsolidate | 1 |
200 | relationship-causation | 1 |
201 | remifentinal | 1 |
202 | restaging/follow-up | 1 |
203 | retro-claisen/retro-hetero-diels-alder | 1 |
204 | rhizomorphs | 1 |
205 | ring-cladding | 1 |
206 | ringer's-pretreated | 1 |
207 | s-oxygenations | 1 |
208 | selective-invasive | 1 |
209 | selenoamides | 1 |
210 | selenomethionine/kg | 1 |
211 | sham-tms | 1 |
212 | single-cpg | 1 |
213 | sirna-knockdown | 1 |
214 | subepimyocardium | 1 |
215 | symptoms/deteriorations | 1 |
216 | tibia-first | 1 |
217 | time-averaging | 1 |
218 | times-to-ponv | 1 |
219 | transanal/perineal | 1 |
220 | trpv1+/peptidergic | 1 |
221 | tyr-vx001 | 1 |
222 | ultra-micro-levels | 1 |
223 | underpresence | 1 |
224 | underprosecution | 1 |
225 | urethrocystoscopic | 1 |
226 | ve-deficient | 1 |
227 | wgt | 1 |
228 | znpic/kg | 1 |
229 | ~1/5 | 1 |
1 | 'characteristics | 2 |
2 | 'proportion | 5 |
3 | 'region | 1 |
4 | 'toxemia | 1 |
5 | 0-6-month | 1 |
6 | 0.1mg/g | 1 |
7 | 0.450mg | 1 |
8 | 16g/day | 1 |
9 | 2,6-dideoxyhexoses | 1 |
10 | 23-o-methylation | 1 |
11 | 3'-amp-induced | 1 |
12 | 3-alkenylation | 3 |
13 | 3-alkylation | 3 |
14 | 3-o-acetylation | 1 |
15 | 3.2g | 1 |
16 | 4'-position | 7 |
17 | 5-methoxy-moieties | 1 |
18 | 54mg | 1 |
19 | 5drop/kg | 1 |
20 | 8,9-positions | 1 |
21 | =2/5 | 1 |
22 | abolishment | 15 |
23 | absence | 9,285 |
24 | absence/presence | 11 |
25 | acute-exacerbations | 1 |
26 | adaptiveness | 8 |
27 | adolescent-report | 1 |
28 | advisability | 20 |
29 | aleviations | 1 |
30 | anatomical/physiological | 1 |
31 | andinjustice | 1 |
32 | antennal- | 1 |
33 | anti-conservatism | 1 |
34 | arg-vx001 | 2 |
35 | arm-forearm | 2 |
36 | avirulence | 2 |
37 | axilla-surgery | 1 |
38 | banishment | 1 |
39 | beef-consumption | 2 |
40 | bprs-score | 1 |
41 | brief-symptom-inventory-18 | 1 |
42 | broadbeam | 1 |
43 | bypass/resection | 1 |
44 | c1-carboxyl | 1 |
45 | ca2+-permeability | 1 |
46 | cattaneo-vernotte | 1 |
47 | cav- | 2 |
48 | cdc28 | 1 |
49 | cdh1-347g/ga | 1 |
50 | cis-regulation | 2 |
51 | clarithromycin-amoxicillin | 1 |
52 | classical- | 1 |
53 | clinical-course | 1 |
54 | co-inhibitors | 1 |
55 | cocirculation | 5 |
56 | conclusiveness | 15 |
57 | conut® | 1 |
58 | county- | 1 |
59 | cu-se | 1 |
60 | culture-negatives | 1 |
61 | curer | 2 |
62 | curve-ness | 2 |
63 | cytodestruction | 1 |
64 | dam-to-placenta | 1 |
65 | decompression/release | 1 |
66 | deimplementation | 1 |
67 | dendrimerization | 1 |
68 | di-sulfate | 1 |
69 | didactic-only | 1 |
70 | disbeliefs | 1 |
71 | disease-spectrum | 1 |
72 | disproof | 1 |
73 | disunity | 2 |
74 | dose/type | 2 |
75 | dw-r. | 1 |
76 | earliness | 4 |
77 | eclabion | 1 |
78 | ecws | 2 |
79 | efficicacy | 2 |
80 | endodrainage | 1 |
81 | enormity | 7 |
82 | entranceability | 1 |
83 | eortc-qlqc30 | 1 |
84 | erk- | 1 |
85 | ethylacetate-fraction | 2 |
86 | eurotiales | 1 |
87 | existence | 1,512 |
88 | explicitness | 3 |
89 | extrudability | 2 |
90 | f-60 | 1 |
91 | face/forehead | 1 |
92 | fracture/operation | 3 |
93 | freguency | 2 |
94 | full-texts | 3 |
95 | gastrin- | 1 |
96 | globality | 1 |
97 | greying | 2 |
98 | gut-hepatic | 1 |
99 | hemorrhea | 1 |
100 | ho/co | 1 |
101 | hydrophosphination | 2 |
102 | hypermethylations | 1 |
103 | hypopnoea/hour | 1 |
104 | imperfectness | 2 |
105 | inhibition/depletion | 2 |
106 | initial-pat | 1 |
107 | instalment | 2 |
108 | intermediating | 1 |
109 | ionicity | 3 |
110 | jeju-do | 1 |
111 | keratitis/keratopathy | 1 |
112 | ldlr-cc | 1 |
113 | levels/patterns | 1 |
114 | liberal- | 1 |
115 | liquidform | 1 |
116 | load-dependence | 2 |
117 | lodogen | 1 |
118 | m-methoxyphenyl | 1 |
119 | maxillary- | 1 |
120 | menbunong | 1 |
121 | mensapo | 1 |
122 | metaregister | 255 |
123 | mid-wbc | 1 |
124 | midazolam-group | 1 |
125 | midvault | 1 |
126 | minutia | 1 |
127 | mono-beta-xyloside | 1 |
128 | mono-ubiquitylation | 1 |
129 | msus- | 1 |
130 | multifunctionality | 3 |
131 | myth-reality | 1 |
132 | n109 | 1 |
133 | naguales | 1 |
134 | near-clearing | 1 |
135 | nerve-nerve | 1 |
136 | newness | 4 |
137 | next-of-kin | 2 |
138 | nhe6 | 1 |
139 | nickel-producing | 1 |
140 | non-adenomatous | 2 |
141 | non-collection | 1 |
142 | non-consumption | 1 |
143 | non-eruption | 2 |
144 | non-occurrence | 6 |
145 | non-presence | 2 |
146 | nonactivation | 1 |
147 | nonexistence | 3 |
148 | nonpractice | 1 |
149 | nonreceipt | 5 |
150 | nonrespect | 1 |
151 | o-iodoanilides | 1 |
152 | ocurrence | 2 |
153 | off-warfarin | 1 |
154 | orchestration | 10 |
155 | over-expressions | 4 |
156 | over-ordination | 1 |
157 | over-recording | 1 |
158 | overgrading | 1 |
159 | overthinning | 1 |
160 | patho-physiology | 5 |
161 | pathoetiology | 5 |
162 | permissibility | 2 |
163 | perpetuation | 47 |
164 | persistence/calcification | 1 |
165 | pervasion | 2 |
166 | pervasiveness | 19 |
167 | petichiae | 1 |
168 | photophysics | 10 |
169 | post-clamping | 1 |
170 | pou5f1- | 1 |
171 | preemption | 1 |
172 | presence | 22,771 |
173 | presence/absence | 109 |
174 | presences | 5 |
175 | principality | 6 |
176 | psc833- | 1 |
177 | pseudo-delayedness | 1 |
178 | purveyor | 1 |
179 | quick-disabilities | 2 |
180 | raloxifene- | 1 |
181 | re-appearance | 3 |
182 | reconsolidate | 1 |
183 | regimentation | 3 |
184 | reinstallation | 2 |
185 | relationship-causation | 1 |
186 | remifentinal | 1 |
187 | restaging/follow-up | 1 |
188 | retro-claisen/retro-hetero-diels-alder | 1 |
189 | revitalisation | 2 |
190 | rhizomorphs | 1 |
191 | ring-cladding | 1 |
192 | ringer's-pretreated | 1 |
193 | rls-quality | 2 |
194 | rv-5h-egfp | 4 |
195 | s-oxygenations | 1 |
196 | score/duration | 2 |
197 | selective-invasive | 1 |
198 | selenoamides | 1 |
199 | selenomethionine/kg | 1 |
200 | shade-drying | 2 |
201 | sham-tms | 1 |
202 | single-cpg | 1 |
203 | sirna-knockdown | 1 |
204 | subepimyocardium | 1 |
205 | sugammadex-rocuronium | 3 |
206 | sultanate | 7 |
207 | supremacy | 10 |
208 | symptoms/deteriorations | 1 |
209 | theorisation | 2 |
210 | thrombovasculitis | 2 |
211 | tibia-first | 1 |
212 | time-averaging | 1 |
213 | timecourse | 2 |
214 | times-to-ponv | 1 |
215 | transactivity | 4 |
216 | transanal/perineal | 1 |
217 | trpv1+/peptidergic | 1 |
218 | type-conformity | 2 |
219 | tyr-vx001 | 1 |
220 | ultra-micro-levels | 1 |
221 | underpresence | 1 |
222 | underprosecution | 1 |
223 | underweighting | 2 |
224 | up-take | 3 |
225 | urethrocystoscopic | 1 |
226 | ve-deficient | 1 |
227 | wgt | 1 |
228 | znpic/kg | 1 |
229 | ~1/5 | 1 |
1 | pou5f1- | 1 |
2 | psc833- | 1 |
3 | raloxifene- | 1 |
4 | erk- | 1 |
5 | classical- | 1 |
6 | antennal- | 1 |
7 | liberal- | 1 |
8 | gastrin- | 1 |
9 | msus- | 1 |
10 | cav- | 2 |
11 | maxillary- | 1 |
12 | county- | 1 |
13 | dw-r. | 1 |
14 | eortc-qlqc30 | 1 |
15 | f-60 | 1 |
16 | arg-vx001 | 2 |
17 | tyr-vx001 | 1 |
18 | ~1/5 | 1 |
19 | =2/5 | 1 |
20 | nhe6 | 1 |
21 | brief-symptom-inventory-18 | 1 |
22 | cdc28 | 1 |
23 | n109 | 1 |
24 | hemorrhea | 1 |
25 | cdh1-347g/ga | 1 |
26 | 'toxemia | 1 |
27 | minutia | 1 |
28 | dam-to-placenta | 1 |
29 | mid-wbc | 1 |
30 | ldlr-cc | 1 |
31 | trpv1+/peptidergic | 1 |
32 | urethrocystoscopic | 1 |
33 | gut-hepatic | 1 |
34 | face/forehead | 1 |
35 | 3'-amp-induced | 1 |
36 | ringer's-pretreated | 1 |
37 | petichiae | 1 |
38 | nonpractice | 1 |
39 | andinjustice | 1 |
40 | re-appearance | 3 |
41 | load-dependence | 2 |
42 | avirulence | 2 |
43 | non-occurrence | 6 |
44 | ocurrence | 2 |
45 | absence | 9,285 |
46 | presence/absence | 109 |
47 | presence | 22,771 |
48 | non-presence | 2 |
49 | absence/presence | 11 |
50 | underpresence | 1 |
51 | existence | 1,512 |
52 | nonexistence | 3 |
53 | mono-beta-xyloside | 1 |
54 | endodrainage | 1 |
55 | up-take | 3 |
56 | dose/type | 2 |
57 | bprs-score | 1 |
58 | cu-se | 1 |
59 | decompression/release | 1 |
60 | clinical-course | 1 |
61 | timecourse | 2 |
62 | reconsolidate | 1 |
63 | di-sulfate | 1 |
64 | sultanate | 7 |
65 | cattaneo-vernotte | 1 |
66 | selective-invasive | 1 |
67 | nerve-nerve | 1 |
68 | disproof | 1 |
69 | 0.1mg/g | 1 |
70 | 3.2g | 1 |
71 | znpic/kg | 1 |
72 | selenomethionine/kg | 1 |
73 | 5drop/kg | 1 |
74 | 0.450mg | 1 |
75 | 54mg | 1 |
76 | nickel-producing | 1 |
77 | overgrading | 1 |
78 | ring-cladding | 1 |
79 | over-recording | 1 |
80 | time-averaging | 1 |
81 | overthinning | 1 |
82 | post-clamping | 1 |
83 | near-clearing | 1 |
84 | intermediating | 1 |
85 | underweighting | 2 |
86 | greying | 2 |
87 | shade-drying | 2 |
88 | menbunong | 1 |
89 | single-cpg | 1 |
90 | 0-6-month | 1 |
91 | anatomical/physiological | 1 |
92 | transanal/perineal | 1 |
93 | remifentinal | 1 |
94 | m-methoxyphenyl | 1 |
95 | c1-carboxyl | 1 |
96 | broadbeam | 1 |
97 | arm-forearm | 2 |
98 | liquidform | 1 |
99 | anti-conservatism | 1 |
100 | subepimyocardium | 1 |
101 | sugammadex-rocuronium | 3 |
102 | disease-spectrum | 1 |
103 | lodogen | 1 |
104 | next-of-kin | 2 |
105 | clarithromycin-amoxicillin | 1 |
106 | off-warfarin | 1 |
107 | eclabion | 1 |
108 | 'region | 1 |
109 | pervasion | 2 |
110 | persistence/calcification | 1 |
111 | reinstallation | 2 |
112 | cocirculation | 5 |
113 | cis-regulation | 2 |
114 | 23-o-methylation | 1 |
115 | 3-alkylation | 3 |
116 | 3-alkenylation | 3 |
117 | 3-o-acetylation | 1 |
118 | mono-ubiquitylation | 1 |
119 | over-ordination | 1 |
120 | hydrophosphination | 2 |
121 | fracture/operation | 3 |
122 | orchestration | 10 |
123 | score/duration | 2 |
124 | revitalisation | 2 |
125 | theorisation | 2 |
126 | relationship-causation | 1 |
127 | deimplementation | 1 |
128 | regimentation | 3 |
129 | perpetuation | 47 |
130 | nonactivation | 1 |
131 | dendrimerization | 1 |
132 | ethylacetate-fraction | 2 |
133 | non-collection | 1 |
134 | bypass/resection | 1 |
135 | cytodestruction | 1 |
136 | inhibition/depletion | 2 |
137 | 4'-position | 7 |
138 | preemption | 1 |
139 | beef-consumption | 2 |
140 | non-consumption | 1 |
141 | non-eruption | 2 |
142 | 'proportion | 5 |
143 | underprosecution | 1 |
144 | sirna-knockdown | 1 |
145 | ho/co | 1 |
146 | jeju-do | 1 |
147 | mensapo | 1 |
148 | rv-5h-egfp | 4 |
149 | restaging/follow-up | 1 |
150 | midazolam-group | 1 |
151 | retro-claisen/retro-hetero-diels-alder | 1 |
152 | curer | 2 |
153 | metaregister | 255 |
154 | purveyor | 1 |
155 | hypopnoea/hour | 1 |
156 | photophysics | 10 |
157 | 'characteristics | 2 |
158 | presences | 5 |
159 | o-iodoanilides | 1 |
160 | selenoamides | 1 |
161 | 5-methoxy-moieties | 1 |
162 | quick-disabilities | 2 |
163 | eurotiales | 1 |
164 | naguales | 1 |
165 | 2,6-dideoxyhexoses | 1 |
166 | culture-negatives | 1 |
167 | disbeliefs | 1 |
168 | rhizomorphs | 1 |
169 | thrombovasculitis | 2 |
170 | ultra-micro-levels | 1 |
171 | sham-tms | 1 |
172 | over-expressions | 4 |
173 | acute-exacerbations | 1 |
174 | aleviations | 1 |
175 | hypermethylations | 1 |
176 | s-oxygenations | 1 |
177 | symptoms/deteriorations | 1 |
178 | 8,9-positions | 1 |
179 | levels/patterns | 1 |
180 | co-inhibitors | 1 |
181 | curve-ness | 2 |
182 | pseudo-delayedness | 1 |
183 | pervasiveness | 19 |
184 | conclusiveness | 15 |
185 | adaptiveness | 8 |
186 | earliness | 4 |
187 | imperfectness | 2 |
188 | explicitness | 3 |
189 | newness | 4 |
190 | full-texts | 3 |
191 | non-adenomatous | 2 |
192 | ecws | 2 |
193 | initial-pat | 1 |
194 | nonrespect | 1 |
195 | wgt | 1 |
196 | midvault | 1 |
197 | ve-deficient | 1 |
198 | abolishment | 15 |
199 | banishment | 1 |
200 | instalment | 2 |
201 | nonreceipt | 5 |
202 | adolescent-report | 1 |
203 | tibia-first | 1 |
204 | times-to-ponv | 1 |
205 | 16g/day | 1 |
206 | efficicacy | 2 |
207 | supremacy | 10 |
208 | freguency | 2 |
209 | patho-physiology | 5 |
210 | pathoetiology | 5 |
211 | keratitis/keratopathy | 1 |
212 | didactic-only | 1 |
213 | axilla-surgery | 1 |
214 | ionicity | 3 |
215 | globality | 1 |
216 | myth-reality | 1 |
217 | multifunctionality | 3 |
218 | principality | 6 |
219 | rls-quality | 2 |
220 | extrudability | 2 |
221 | entranceability | 1 |
222 | ca2+-permeability | 1 |
223 | advisability | 20 |
224 | permissibility | 2 |
225 | type-conformity | 2 |
226 | enormity | 7 |
227 | disunity | 2 |
228 | transactivity | 4 |
229 | conut® | 1 |